T1	PROC 46 68	Ensayo investigacional
T2	PROC 72 85	inmunoterapia
#1	AnnotatorNotes T2	C0021083; Immunotherapy; Therapeutic or Preventive Procedure
T3	PROC 102 113	monoterapia
#2	AnnotatorNotes T3	C4763675; Single Agent Therapy; Therapeutic or Preventive Procedure
T4	CHEM 116 125	nivolumab
#3	AnnotatorNotes T4	C3657270; nivolumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T5	CHEM 145 155	ipilimumab
#4	AnnotatorNotes T5	C1367202; ipilimumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T6	DISO 185 222	neoplasias malignas primarias del SNC
#5	AnnotatorNotes T6	C1455806; Primary malignant neoplasm of central nervous system; Neoplastic Process
T7	DISO 620 624	GPID
T8	ANAT 219 222	SNC
#6	AnnotatorNotes T8	C1269563; Entire central nervous system; Body System | C3714787; Central Nervous System; Body System
T9	PROC 260 285	Ensayo clínico fase Ib/II
T10	CHEM 289 298	nivolumab
#7	AnnotatorNotes T10	C3657270; nivolumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T11	PROC 302 313	monoterapia
#8	AnnotatorNotes T11	C4763675; Single Agent Therapy; Therapeutic or Preventive Procedure
T12	CHEM 316 325	nivolumab
#9	AnnotatorNotes T12	C3657270; nivolumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T13	CHEM 345 355	ipilimumab
#10	AnnotatorNotes T13	C1367202; ipilimumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T14	DISO 385 422	neoplasias malignas primarias del SNC
#11	AnnotatorNotes T14	C1455806; Primary malignant neoplasm of central nervous system; Neoplastic Process
T15	DISO 701 716	tumores del SNC
#12	AnnotatorNotes T15	C0085136; Central Nervous System Neoplasms; Neoplastic Process
T16	ANAT 419 422	SNC
#13	AnnotatorNotes T16	C1269563; Entire central nervous system; Body System | C3714787; Central Nervous System; Body System
T17	DISO 461 498	Neoplasias malignas primarias del SNC
#14	AnnotatorNotes T17	C1455806; Primary malignant neoplasm of central nervous system; Neoplastic Process
T18	ANAT 927 944	muestra del tumor
T19	ANAT 495 498	SNC
#15	AnnotatorNotes T19	C1269563; Entire central nervous system; Body System | C3714787; Central Nervous System; Body System
T20	PROC 564 578	diagnosticados
#16	AnnotatorNotes T20	C0011900; Diagnosis; Diagnostic Procedure
T21	DISO 586 618	Glioma Pontino Intrinseco Difuso
#17	AnnotatorNotes T21	C2986658; Diffuse Intrinsic Pontine Glioma; Neoplastic Process
T22	ANAT 593 600	Pontino
#18	AnnotatorNotes T22	C0032639; Pontine structure; Body Part, Organ, or Organ Component
T23	DISO 629 649	Glioma de Alto Grado
#19	AnnotatorNotes T23	C4722099; High grade glioma; Neoplastic Process
T24	DISO 660 674	Meduloblastoma
#20	AnnotatorNotes T24	C0025149; Medulloblastoma; Neoplastic Process
T25	DISO 678 688	Ependimoma
#21	AnnotatorNotes T25	C0014474; Ependymoma; Neoplastic Process
T26	ANAT 713 716	SNC
#22	AnnotatorNotes T26	C1269563; Entire central nervous system; Body System | C3714787; Central Nervous System; Body System
T27	PROC 782 801	índice de Karnofsky
#23	AnnotatorNotes T27	C0206065; Karnofsky Performance Status; Diagnostic Procedure
T28	PROC 803 806	KPS
#24	AnnotatorNotes T28	C0206065; Karnofsky Performance Status; Diagnostic Procedure
T29	DISO 939 944	tumor
#25	AnnotatorNotes T29	C0006826; Malignant Neoplasms; Neoplastic Process | C0027651; Neoplasms; Neoplastic Process | C0577559; Mass of body structure; Finding
T30	DISO 1053 1074	enfermedad autoinmune
#26	AnnotatorNotes T30	C0004364; Autoimmune Diseases; Disease or Syndrome
T31	CHEM 1166 1176	esteroides
#27	AnnotatorNotes T31	C0038317; Steroids; Organic Chemical · Pharmacologic Substance
T32	DISO 1206 1211	tumor
#28	AnnotatorNotes T32	C0006826; Malignant Neoplasms; Neoplastic Process | C0027651; Neoplasms; Neoplastic Process | C0577559; Mass of body structure; Finding
T33	DISO 1230 1250	glioma de bajo grado
#29	AnnotatorNotes T33	C1997217; Low grade glioma; Neoplastic Process
T34	DISO 1253 1293	tumores de potencial maligno desconocido
#30	AnnotatorNotes T34	C0154129; Neoplastic disease of uncertain behavior; Neoplastic Process
T35	PROC 1330 1341	tratamiento
#31	AnnotatorNotes T35	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T36	CHEM 1363 1416	medicamento dirigido a la coestimulación de células T
#32	AnnotatorNotes T36	C3192215; Selective T Cell Costimulation Blocker; Pharmacologic Substance (?)
T37	ANAT 1407 1416	células T
#33	AnnotatorNotes T37	C0039194; T-Lymphocyte; Cell
T38	CHEM 1427 1459	inhibidores del punto de control
#34	AnnotatorNotes T38	C4684977; Immune Checkpoint Inhibitor; Immunologic Factor · Pharmacologic Substance
T39	CHEM 89 98	nivolumab
#35	AnnotatorNotes T39	C3657270; nivolumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T40	DISO 1003 1007	GPID
T41	Date 13 17	2016
T42	LIVB 159 180	pacientes pediátricos
#36	AnnotatorNotes T42	C0030705; Patients; Patient or Disabled Group + C0008059; Child; Age Group
T43	LIVB 359 380	pacientes pediátricos
#37	AnnotatorNotes T43	C0030705; Patients; Patient or Disabled Group + C0008059; Child; Age Group
T44	LIVB 543 548	Niños
#38	AnnotatorNotes T44	C0008059; Child; Age Group
T45	Age 762 771	≤ 16 años
T46	Age 813 822	> 16 años
T47	Duration 850 865	las dos semanas
T49	LIVB 1039 1048	Pacientes
#39	AnnotatorNotes T49	C0030705; Patients; Patient or Disabled Group
T50	Spec_cue 1093 1103	sospechada
T51	LIVB 1108 1117	Pacientes
#40	AnnotatorNotes T51	C0030705; Patients; Patient or Disabled Group
T54	LIVB 1216 1225	Pacientes
#41	AnnotatorNotes T54	C0030705; Patients; Patient or Disabled Group
T56	LIVB 1298 1307	Pacientes
#42	AnnotatorNotes T56	C0030705; Patients; Patient or Disabled Group
T57	LIVB 551 563	adolescentes
#43	AnnotatorNotes T57	C0205653; Adolescent (age group); Age Group
T48	PROC 1144 1162	disminuir la dosis
#44	AnnotatorNotes T48	C2348004; Agent Dose Decreased; Therapeutic or Preventive Procedure
T52	Neg_cue 1129 1131	no
T53	PHYS 1389 1416	coestimulación de células T
#45	AnnotatorNotes T53	C1622572; T cell costimulation; Cell Function
T55	PROC 869 882	reclutamiento
#46	AnnotatorNotes T55	C0242800; Patient Recruitment; Research Activity
A1	Population_data T44 Age
A2	Population_data T57 Age
A3	Population_data T42 Age
A4	Population_data T43 Age
A5	Assertion T30 Speculated
A6	Assertion T48 Negated
A7	Status T35 History_of
A8	Status T36 History_of
A9	Status T30 History_of
A10	Status T38 History_of
#47	AnnotatorNotes T1	C0681814; research study; Research Activity 
#48	AnnotatorNotes T7	C2986658; Diffuse Intrinsic Pontine Glioma; Neoplastic Process
#49	AnnotatorNotes T40	C2986658; Diffuse Intrinsic Pontine Glioma; Neoplastic Process
R1	Used_for Arg1:T39 Arg2:T2	
R2	Combined_with Arg1:T4 Arg2:T5	
R3	Used_for Arg1:T39 Arg2:T3	
R4	Used_for Arg1:T4 Arg2:T2	
R5	Experiences Arg1:T42 Arg2:T3	
R6	Experiences Arg1:T42 Arg2:T2	
R7	Location_of Arg1:T8 Arg2:T6	
T58	Quantifier_or_Qualifier 226 236	alto grado
R8	Has_Quantifier_or_Qualifier Arg1:T6 Arg2:T58	
T59	Quantifier_or_Qualifier 426 436	alto grado
R9	Location_of Arg1:T16 Arg2:T14	
R10	Has_Quantifier_or_Qualifier Arg1:T14 Arg2:T59	
R11	Experiences Arg1:T43 Arg2:T14	
R12	Experiences Arg1:T42 Arg2:T6	
R13	Used_for Arg1:T10 Arg2:T11	
R14	Combined_with Arg1:T12 Arg2:T13	
R15	Experiences Arg1:T43 Arg2:T12	
R16	Experiences Arg1:T43 Arg2:T10	
T60	Quantifier_or_Qualifier 502 512	alto grado
R17	Location_of Arg1:T19 Arg2:T17	
R18	Has_Quantifier_or_Qualifier Arg1:T17 Arg2:T60	
R21	Location_of Arg1:T22 Arg2:T21	
R22	Location_of Arg1:T22 Arg2:T7	
R24	Location_of Arg1:T26 Arg2:T15	
T62	Quantifier_or_Qualifier 720 730	alto grado
R25	Has_Quantifier_or_Qualifier Arg1:T15 Arg2:T62	
T63	CONC 734 750	Escala de Lansky
#50	AnnotatorNotes T63	C1522275; Lansky Play-Performance Status; Classification
T64	CONC 752 755	LPS
R26	Overlap Arg1:T28 Arg2:T47	
T65	Result_or_Value 892 896	≥ 60
R27	Has_Result_or_Value Arg1:T28 Arg2:T65	
R28	Has_Result_or_Value Arg1:T27 Arg2:T65	
R29	Has_Result_or_Value Arg1:T64 Arg2:T65	
#51	AnnotatorNotes T64	C1522275; Lansky Play-Performance Status; Classification
R30	Has_Result_or_Value Arg1:T63 Arg2:T65	
R31	Has_Duration_or_Interval Arg1:T55 Arg2:T47	
R32	Overlap Arg1:T27 Arg2:T47	
R33	Overlap Arg1:T64 Arg2:T47	
R34	Overlap Arg1:T63 Arg2:T47	
#52	AnnotatorNotes T18	C0475358; Tumor tissue sample; Tissue
T66	CONC 986 997	se requiere
A11	Assertion T66 Negated
T67	Neg_cue 983 985	no
R35	Negation Arg1:T67 Arg2:T66	
R36	Experiences Arg1:T49 Arg2:T30	
R37	Speculation Arg1:T50 Arg2:T30	
R38	Negation Arg1:T52 Arg2:T48	
R39	Used_for Arg1:T31 Arg2:T48	
R40	Experiences Arg1:T51 Arg2:T48	
R41	Experiences Arg1:T51 Arg2:T32	
R42	Experiences Arg1:T54 Arg2:T33	
R44	Experiences Arg1:T54 Arg2:T34	
R45	Experiences Arg1:T56 Arg2:T35	
R46	Used_for Arg1:T36 Arg2:T35	
R47	Experiences Arg1:T56 Arg2:T53	
R48	Location_of Arg1:T37 Arg2:T53	
R49	Used_for Arg1:T38 Arg2:T35	
T69	Quantifier_or_Qualifier 1075 1081	activa
R50	Has_Quantifier_or_Qualifier Arg1:T30 Arg2:T69	
R51	Experiences Arg1:T42 Arg2:T4	
T61	Spec_cue 1264 1273	potencial
T68	Observation 1274 1281	maligno
A12	Assertion T68 Speculated
R23	Speculation Arg1:T61 Arg2:T68	
T70	Spec_cue 1282 1293	desconocido
R43	Speculation Arg1:T70 Arg2:T68	
#53	AnnotatorNotes T69	C0679217; Active State; Idea or Concept
T71	Observation 1187 1201	efecto de masa
#54	AnnotatorNotes T71	C4086564; Mass Effect; Finding
R19	Causes Arg1:T32 Arg2:T71	
R20	Experiences Arg1:T51 Arg2:T71	
#55	AnnotatorNotes T58	C5547531; High histologic grade; Classification
#56	AnnotatorNotes T60	C5547531; High histologic grade; Classification
#57	AnnotatorNotes T62	C5547531; High histologic grade; Classification
#58	AnnotatorNotes T59	C5547531; High histologic grade; Classification
A13	Experiencer T51 Patient
A14	Experiencer T49 Patient
A15	Experiencer T56 Patient
A16	Experiencer T54 Patient
A17	Experiencer T57 Patient
A18	Experiencer T44 Patient
A19	Experiencer T42 Patient
A20	Experiencer T43 Patient
